These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 6604958)

  • 1. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
    Aleksandrova EN; Zimin IuI; Nasonov EL
    Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunology and rheumatic diseases. History and current aspects].
    Bonomo L
    Recenti Prog Med; 1976 Dec; 61(6):741-8. PubMed ID: 1088188
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunology of rheumatoid diseases.
    Koffler D
    Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of glucocorticosteroid and cytotoxic therapy on the natural cytotoxicity in rheumatic diseases].
    Aleksandrova EN; Nasonov EL
    Ter Arkh; 1985; 57(8):34-7. PubMed ID: 4071433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the laboratory in rheumatology. Lymphocytes.
    Russell AS; Edelman J
    Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
    Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
    J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Humoral reactivity against the secretory component of secretory IgA in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus].
    Luft S; Brzezińska B; Wójcik-Scisłowska M; Małdykowa H; Pazdur J; Strauss MM
    Reumatologia; 1979; 17(2):137-43. PubMed ID: 472524
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
    Kurki P; Helve T; Virtanen I
    J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immune complexes in rheumatoid arthritis.
    Bozsóky S; Merétey K; Falus A
    Ann Immunol Hung; 1979; 19():117-35. PubMed ID: 399579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field].
    Biddau A; Bartoletti L; Doni A
    Reumatismo; 1968; 20(5):545-9. PubMed ID: 4186692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological changes in the course of various rheumatic diseases in children. Cryoglobulins].
    Mignone F; Chiappo GF; Cordero A; Vighetti A; Licata D; Oggero R
    Minerva Pediatr; 1979 Apr; 31(7):515-20. PubMed ID: 313506
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases].
    Fabregas-Canales D; Meyer O; Haim T; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cryoglobulinemia in rheumatic diseases].
    Baranauskaĭte AA; Nasonov EL; Solov'ev SK
    Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.